Form D · Biotechnology
Kineta Two, LLC
Seattle, WA · CIK 0001492313
Offering snapshot reported May 31, 2016 · SEC filing
- Reported sold
- $67.3K Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Mar 17, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 31, 2016 | Initial | $67,275 | No comparison | 1 | SEC filing |
| Feb 4, 2013 | Initial | $2,737,052 | No comparison | 61 | SEC filing |
| Jun 23, 2010 | Initial | $134,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-264096
Source: Form D, filed May 31, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shawn Iadonato, Ph.D. | Executive |
| Charles Magness, Ph.D. | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
219 Terry Ave N. Suite 300
Seattle, WA, 98109-5208
Seattle, WA, 98109-5208